Skip to content

Construction and Feasibility Study of a Phased VILPA Intervention Program for Postoperative Chemotherapy Breast Cancer Patients Based on Chemotherapy Cycle Characteristics

Construction and Feasibility Study of a Phased VILPA Intervention Program for Postoperative Chemotherapy Breast Cancer Patients Based on Chemotherapy Cycle Characteristics

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600124995
Enrollment
Unknown
Registered
2026-05-20
Start date
2026-05-20
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

Control group:Control group patients received "standard care plus general exercise advice." Standard care refers to the routine nursing procedures during chemotherapy, including monitoring of chemothe
Intervention Group:Intervention Group: Patients in the intervention group received "standard care plus phased VILPA intervention."

Sponsors

The Second Affiliated Hospital of Hainan Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Histologically or cytologically confirmed invasive breast cancer, TNM stage I–III. 2.Planned to receive, or currently receiving, AC regimen chemotherapy (doxorubicin/epirubicin plus cyclophosphamide) with a 21-day cycle; total planned cycles >= 4. Patients may be enrolled either before the first chemotherapy cycle or within 7 days after the first cycle. 3.Age 18–70 years, with Eastern Cooperative Oncology Group (ECOG) performance status 0–1. 4.Possession of a smartphone with basic operational skills and adequate cognitive function (Mini-Mental State Examination [MMSE] score >= 24). 5.Signed informed consent, willing to participate in the study, and committed to comply with follow-up.

Exclusion criteria

Exclusion criteria: 1.History of myocardial infarction, unstable angina, congestive heart failure, or serious arrhythmias, or resting electrocardiogram showing significant abnormalities. 2.Severe musculoskeletal disorders or confirmed bone metastases. 3.Baseline hematology showing neutrophil count = 20). 6.Participation in other exercise intervention studies or having performed systematic exercise training in the past 6 months (>=3 sessions per week,>=30 minutes per session). 7.Pregnant or breastfeeding women.

Design outcomes

Primary

MeasureTime frame
Symptom Clusters Assessment;Hematological and Biochemical Parameters Assessment;

Secondary

MeasureTime frame
Quality of Life Assessment;Physical Function;VILPA Adherence;

Countries

China

Contacts

Public ContactGong Zhixun

The Second Affiliated Hospital of Hainan Medical University

52430971@qq.com+86 135 1808 5198

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026